Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Mytilinaiou
FRI0224 Rituximab Selectively Reduces Igg4 Levels in Rheumatoid Arthritis Patients
Related publications
Rituximab Therapy in Greek Patients With Rheumatoid Arthritis
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Safety of Rituximab in Rheumatoid Arthritis
Reumatismo
Rheumatology
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Rituximab Hypersensitivity in IgG4-related Disease: Successful Desensitization in a Patient With IgG4 Rheumatoid Factor
International Journal of Rheumatic Diseases
Rheumatology
Serum Serotonin Levels and Bone in Rheumatoid Arthritis Patients
Rheumatology International
Rheumatology
Allergy
Immunology
Serum Fetuin-A Levels in Patients With Rheumatoid Arthritis
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Serological Markers Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Rituximab
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Factors Correlated With Improvement of Endothelial Dysfunction During Rituximab Therapy in Patients With Rheumatoid Arthritis
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Clinical and Immunological Effects of the Original and Biosimilar Rituximab in Patients With Rheumatoid Arthritis
Clinical pharmacology and therapy